The Korea Journal of Herbology (대한본초학회지)

The Korea Association of Herbology (대한본초학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of Coptidis Rhizoma Herbal Acupuncture Extract on the Acute Gastric Mucosal Lesion Progression Induced by Compound 48/80 in Rats

  • Received : 2012.12.27
  • Accepted : 2013.01.14
  • Published : 2013.01.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : Coptidis Rhizoma has been used for stomach disease. However, its property is so cold that it might be avoided to prescribe for the elderly and the infirm having indigestion or diarrhea. Accordingly, the present study was designed to investigate the protective effects of Coptidis Rhizoma herbal acupuncture extract against acute gastric mucosal lesions induced by compound 48/80 in rats. Methods : The Coptidis Rhizoma herbal acupuncture (CRHA) was injected in Choksamni and Chungwan 1 h before compound 48/80 treatment. The animals were sacrificed under anesthesia 3 h after compound 48/80 treatment. The stomachs were removed and the amount of gastric adherent mucus, gastric mucosal hexosamine, SOD, XO, TBARS and histological examination were performed. Results : The decline of gastric adherent mucus, gastric mucosal hexosamine and the histological defects of gastric mucus were significantly protected by CRHA treatment. Gastric adherent mucus in control group was reduced to $38.2{\pm}5.0%$. CRHA groups significantly protected the loss of mucus to $77.5{\pm}4.9%$. Mucosal hexosamine content showed similar patterns. Mucosal hexosamine content in control group was reduced to $45.2{\pm}6.2%$. CRHA groups significantly protected the loss of mucus to $83.0{\pm}7.0%$. The changes of gastric mucosal SOD and TBARS were recovered by CRHA treatment as well. Conclusions : CRHA showed the protective effects on the acute gastric mucosal lesions induced by compound 48/80 in rats. These results suggest that CRHA may have protective effects on the gastritis.

Keywords

References

  1. Kim IR, Kim HC, Kuk YB, Park SJ, Park YK, Park JH, Seo BI, Seo YB, Song HJ, Shin MK, Lee YJ, Lee YC, Lee JH, Leem KH, Cho SI, Chung JK, Joo YS, Choi HY. Boncho‐Hak. Seoul : Young‐Lim Press. 2007 : 218‐21.
  2. Bensky D, Clavey S, Stoger E. Materia Medica 3rd Ed. WA : Eastland Press. 2004 : 134-8.
  3. Schubert ML. Gastric secretion. Curr Opin Gastroenterol. 2005 ; 21(6) : 636‐43. https://doi.org/10.1097/01.mog.0000181713.89281.14
  4. Enerback L, Lundin PM. Ultrastructure of mucosal mast cells in normal and compound 48‐80‐treated rats. Cell Tissue Res. 1974 ; 150(1) : 95‐105.
  5. Irman‐Florjanc T, Erjavec F. Compound 48/80 and substance P induced release of histamine and serotonin from rat peritoneal mast cells. Agents Actions. 1983 ; 13(2‐3) : 138‐41. https://doi.org/10.1007/BF01967317
  6. Kobayashi T, Ohta Y, Inui K, Yoshino J, Nakazawa S. Protective effect of omeprazole against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. Pharmacol Res. 2002 ; 46(1) : 75‐84. https://doi.org/10.1016/S1043-6618(02)00034-8
  7. Ohta Y, Kobayashi T, Hayashi T, Inui K, Yoshino J, Nakazawa S. Preventive effect of Shigyaku‐san on progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. Phytother Res. 2006 ; 20(4) : 256‐62. https://doi.org/10.1002/ptr.1832
  8. Ohta Y, Kamiya Y, Imai Y, Arisawa T, Nakano H. Plaunotol prevents the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. Pharmacology. 2005 ; 74(4) : 182‐92. Epub 2005 Apr https://doi.org/10.1159/000085388
  9. Ohta Y, Kobayashi T, Inui K, Yoshino J, Nakazawa S. Protective effect of teprenone against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. J Pharmacol Sci. 2003 ; 93(3) : 337‐46. https://doi.org/10.1254/jphs.93.337
  10. Ohta Y, Kobayashi T, Inui K, Yoshino J, Nakazawa S.Protective effect of ebselen, a selenoorganic compound, against the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. Jpn J Pharmacol. 2002 ; 90(4) : 295‐303. https://doi.org/10.1254/jjp.90.295
  11. Grisham MB, Von Ritter C, Smith BF, Lamont JT, Granger DN. Interaction between oxygen radicals and gastric mucin. Am J Physiol. 1987 ; 253(1 Pt 1) : G93‐6.
  12. Tian L, Huang YX, Tian M, Gao W, Chang Q. Downregulation of electroacupuncture at ST36 on TNF‐alpha in rats with ulcerative colitis. World J Gastroenterol. 2003 ; 9(5) : 1028‐33. https://doi.org/10.3748/wjg.v9.i5.1028
  13. Chang SL, Lin JG, Chi TC, Liu IM, Cheng JT. An insulin‐dependent hypoglycaemia induced by electroacupuncture at the Zhongwan (CV12) acupoint in diabetic rats. Diabetologia. 1999 ; 42(2) : 250‐5. https://doi.org/10.1007/s001250051146
  14. Kitagawa H, Takeda F, Kohei H. A simple method for estimation of gastric mucus and effects of antiulcerogenic agents on the decrease in mucus during water‐immersion stress in rats. Arzneimittelforschung. 1986 ; 36(8) : 1240‐4.
  15. Wang QS, Cui YL, Dong TJ, Zhang XF, Lin KM. Ethanol extract from a Chinese herbal formula,"Zuojin Pill", inhibit the expression of inflammatory mediators in lipopolysaccharidestimulated RAW 264.7 mouse macrophages. J Ethnopharmacol. 2012 ; 141(1) : 377‐85. https://doi.org/10.1016/j.jep.2012.02.049
  16. Yu Q, Huang H, Cao L. Clinical Observation of Modified Huazhuo Jiedu Qingyou Recipe for Treatment of Helicobacter pylori Associated Gastritis. J Guangzhou Univ Trad Med/Guangzhou Zhongyiyao Daxue Xuebao. 2012 ; 29(2) : 139‐41.
  17. Hong‐jun QI. "Phlegm‐Resolving and Collateral‐ Unblocking Decoction" for Bile‐Regurgitational Gastritis in 56 Cases. Shnghai J Trad Chin Med. 2004 ; 6 : 013.
  18. Ji WS, Gao ZX, Wu KC, Qui J, Shi BL, Fan DM. Effect of Hewei‐Decoction on chronic atrophic gastritis and eradication of Helicobacter pylori. World J Gastroenterol. 2005 ; 11(7) : 986‐9. https://doi.org/10.3748/wjg.v11.i7.986
  19. Zhang L, Yang L, Zheng X. A study of Helicobacterium pylori and prevention and treatment of chronic atrophic gastritis. J Trad Chin Med. 1997 ; 17(1) : 3‐9
  20. Müller T, Myrtek D, Bayer H, Sorichter S, Schneider K, Zissel G, Norgauer J, Idzko M. Functional characterization of histamine receptor subtypes in a human bronchial epithelial cell line. Int J Mol Med. 2006 ; 18(5) : 925‐31.
  21. Giusi G, Facciolo RM, Alo R, Carelli A, Madeo M, Brandmayr P, Canonaco M. Some environmental contaminants influence motor and feeding behaviors in the ornate wrasse (Thalassoma pavo) via distinct cerebral histamine receptor subtypes. Environ Health Perspect. 2005 ; 113(11) : 1522‐9. https://doi.org/10.1289/ehp.7983
  22. Nguyen T, Shapiro DA, George SR, Setola V, Lee DK, Cheng R, Rauser L, Lee SP, Lynch KR, Roth BL, O'Dowd BF. Discovery of a novel member of the histamine receptor family. Mol Pharmacol. 2001 ; 59(3) : 427‐33.
  23. Nowak JZ, Sek B, D'Souza T, Dryer SE. Does histamine stimulate cyclic AMP formation in the avian pineal gland via a novel (non‐H1, non‐H2, non‐H3) histamine receptor subtype. Neurochem Int. 1995 ; 27(6) : 519‐26. https://doi.org/10.1016/0197-0186(95)80010-I
  24. Arrang JM. Pharmacological properties of histamine receptor subtypes. Cell Mol Biol (Noisy‐le‐grand). 1994 ; 40(3) : 275‐81.
  25. Kamada T, Hata J, Kusunoki H, Sugiu K, Ito M, Tanaka S, Kawamura Y, Chayama K, Haruma K. Effect of long‐term half‐dose famotidine therapy on corpus gastritis in peptic ulcer disease. Aliment Pharmacol Ther. 2005 ; 21 Suppl 2 : 99‐104.
  26. Williamson KK, Willard MD, McKenzie EC, Royer CM, Payton ME, Davis MS. Efficacy of famotidine for the prevention of exercise‐induced gastritis in racing Alaskan sled dogs. J Vet Intern Med. 2007 ; 21(5) : 924‐7. https://doi.org/10.1111/j.1939-1676.2007.tb03044.x
  27. Na CS, Kim JS, An YS, Pak SC, Kim JS. Effects of aqua‐acupuncture using UrsiFel∙Bovis Calculus, Susi Fel∙Bovis Calculus on the gastric motility in rats. Kor J Orient Int Med. 1998 ; 19(1) : 318‐28.
  28. Lee KM, Lee SY, Lim SC, Seo JC, Han SW. Two cases of chronic gastritis treated with Wihwa herbal‐acupuncture. J of Korean Acupuncture & Moxibustion Society. 2003 ; 20(6) : 218‐25.
  29. Joo JH. Dangaesimbub. Seoul : Dae Sung publishing company. 1982 : 503‐9.
  30. Yun H, Kim YJ, Yun JA, Yu YC, Kim KS, Kang BK. Effects of combined electro‐acupuncture and moxibustion at CV13, CV12, CV10 and ST36 on the serum gastrin level in rats. J Korean Acupuncture & Moxibustion Society. 2004 ; 21(6) : 167‐76.
  31. Hwang WJ, RyuIS. Neurologic study of acupuncture ST36 on gastric motility in rats. J Korean Acupuncture & Moxibustion Society. 2000 ; 17(1) : 119‐27.
  32. Lee MJ, Lee JM. Effects of aqua‐acupuncture with Os Sepiae at Cheun‐chu(S25) and Jung‐wan(CV12) on gastric ulcer induced by indomethacin in rat. J Korean Acupuncture & Moxibustion Society. 1995 ; 12(2) : 209‐18.
  33. Katsurahara M, Kobayashi Y, Iwasa M, Ma N, Inoue H, Fujita N, Tanaka K, Horiki N, Gabazza EC, Takei Y. Reactive nitrogen species mediate DNA damage in Helicobacter pylori‐infected gastric mucosa. Helicobacter. 2009 ; 14(6) : 552‐8. https://doi.org/10.1111/j.1523-5378.2009.00719.x
  34. Handa O, Naito Y, Takagi T, Shimozawa M, Kokura S, Yoshida N, Matsui H, Cepinskas G, Kvietys PR, Yoshikawa T. Tumor necrosis factoralpha‐ induced cytokine‐induced neutrophil chemoattractant‐1 (CINC‐1) production by rat gastric epithelial cells: role of reactive oxygen species and nuclear factor‐kappaB. J Pharmacol Exp Ther. 2004 ; 309(2) : 670‐6. https://doi.org/10.1124/jpet.103.062216
  35. Kwiecien S, Brzozowski T, Konturek PCh, Konturek SJ. The role of reactive oxygen species in action of nitric oxide‐donors on stress‐induced gastric mucosal lesions. J Physiol Pharmacol. 2002 ; 53(4 Pt 2) : 761‐73.
  36. Bagchi D, McGinn TR, Ye X, Bagchi M, Krohn RL, Chatterjee A, Stohs SJ. Helicobacter pyloriinduced oxidative stress and DNA damage in a primary culture of human gastric mucosal cells. Dig Dis Sci. 2002 ; 47(6) : 1405‐12. https://doi.org/10.1023/A:1015399204069
  37. Hille R. Molybdenum‐containing hydroxylases. Arch Biochem Biophys. 2005 ; 433(1) : 107‐16. https://doi.org/10.1016/j.abb.2004.08.012
  38. Harrison R. Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med. 2002 ; 33(6) : 774‐97. https://doi.org/10.1016/S0891-5849(02)00956-5